Fifth Lane Capital’s Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share PHYT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,000
Closed -$14K 364
2021
Q4
$14K Buy
+25,000
New +$14.1K 0.01% 262

Other funds holding PHYT.WS

Fifth Lane Capital's PHYT.WS Position: Q1 2022 in Review

Fifth Lane Capital sold out of Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (PHYT.WS) in Q1 2022, closing a stake of 25,000 shares — an estimated $14K sold.

Fifth Lane Capital first reported a position in PHYT.WS in Q4 2021 and held it in 1 quarter. The position peaked at $14K in Q4 2021. 32 funds tracked by Wall St. Rank hold PHYT.WS as of Q1 2022.

  • Fifth Lane Capital reported no remaining Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 25,000 Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2022, an estimated $14K.
  • Fifth Lane Capital first reported a position in Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 1 quarter.
  • Fifth Lane Capital's Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $14K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2022.

Based on Fifth Lane Capital's 13F filing for Q1 2022, filed 16 May 2022.